{"podcast":{"title":"This Week in Intelligent Investing","slug":"this-week-in-intelligent-investing-744474","podcast_index_feed_id":744474,"rss_url":"https://feed.podbean.com/twiii/feed.xml","website_url":"https://twiii.podbean.com","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/9208617/this_week_in_intelligent_investing_8f1up.jpg","author":"John Mihaljevic and Elliot Turner","episode_count":100,"summary":"This Week in Intelligent Investing examines timely and timeless investment topics to help you become a better investor. Enjoy authentic, unscripted discussion. The podcast is brought to you exclusively by MOI Global, the research-driven membership organization of intelligent investors. Your hosts are Elliot Turner, Chief Investment Officer of RGA Investment Advisors, and John Mihaljevic, Chairman of MOI Global.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/this-week-in-intelligent-investing-744474"},"episode":{"title":"Peter Mantas on the Coiled Spring of Biotech: FDA Shakeups, uniQure's Breakthrough, and AI Drug Discovery","slug":"peter-mantas-on-the-coiled-spring-of-biotech-fda-shakeups-uniqure-s-breakthrough-and-ai-drug-discovery","published_at":"2026-05-13T09:19:57+00:00","page_url":"https://stenobird.com/podcast/this-week-in-intelligent-investing-744474/peter-mantas-on-the-coiled-spring-of-biotech-fda-shakeups-uniqure-s-breakthrough-and-ai-drug-discovery","show_page_url":"https://stenobird.com/podcast/this-week-in-intelligent-investing-744474","url":"https://twiii.podbean.com/e/peter-mantas-on-the-coiled-spring-of-biotech-fda-shakeups-uniqures-breakthrough-and-ai-drug-discovery/","audio_url":"https://mcdn.podbean.com/mf/web/p87qhju2k9w3hmu6/twiii-peter-mantas-20260513-auphonic.mp3","summary":"In this episode of This Week in Intelligent Investing, hosts John Mihaljevic and Elliot Turner welcome Peter Mantas, General Partner and Chief Investment Officer at Logos LP. Recorded on May 12, 2026, the discussion dives deep into the rapidly shifting landscape of biotechnology and life sciences investing.","meta_description":"In this episode of This Week in Intelligent Investing, hosts John Mihaljevic and Elliot Turner welcome Peter Mantas, General Partner and Chief Investment…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3242,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/this-week-in-intelligent-investing-744474/episodes/peter-mantas-on-the-coiled-spring-of-biotech-fda-shakeups-uniqure-s-breakthrough-and-ai-drug-discovery/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/this-week-in-intelligent-investing-744474/peter-mantas-on-the-coiled-spring-of-biotech-fda-shakeups-uniqure-s-breakthrough-and-ai-drug-discovery.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}